Cellular basis of hiv infection of the cns and the aids dementia complex: Oligodendrocyte

Journal of Neuro-AIDS

Volumn 1, Issue 1, 1995, Pages 133-160

  Esiri, Margaret M ^a   Morris, Christine S ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

AIDS; Dementia; HIV; Myelin; Oligodendrocyte

Indexed keywords

MYELIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; DEMENTIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; OLIGODENDROGLIA;

AIDS ARTERITIS, CENTRAL NERVOUS SYSTEM; AIDS DEMENTIA COMPLEX; BRAIN; HUMANS; OLIGODENDROGLIA;

EID: 0030044578     PISSN: 10697438     EISSN: None     Source Type: Journal    
DOI: 10.1300/J128v01n01_07     Document Type: Article

References (113)

1. Achim CL, Morey MK, Wiley CA (1991) Expression of major histocompatibility complex and HIV antigens within the brains of AIDS patients. AIDS 5: 535-41.
2. Allen IV and Kirk J (1992) Demyelinating diseases. In Adams JH, Duchen LW (Eds) Greenfield’s Neuropathology. 5th Ed, Arnold, London pp. 447-521.
3. Anders KH, Guerra WF, Tomiyasu U, Veritz MA, Vinters HV (1986) The neuropathology of AIDS. UCLA experience and review. Am J Pathol 124: 537-58.
4. Antel JP, Williams K, Blain M, McRea E, McLaurin JA (1994) Oligodendrocyte lysis by CD4+ T cells independent of tumour necrosis factor. Ann Neurol 35: 341-48.
5. Benveniste EN, Merrill JE (1986) Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature (Lond) 321: 610-13.
6. Berger JR, Sheremata WA, Resnick L, Atherton S, Fletcher MA, Norenberg M (1989) Multiple sclerosis-like illness occurring with HIV infection. Neurology 39:324-29.
7. Berger JR, Tornatore C, Major EO, Bruce J, Shapshak P, Yoshioka M, Houff S, Sheremata W, Horton CF, Laidy H (1992) Relapsing and remitting HIV- associated leukoencephalopathy. Ann Neurol 31:34-38.
8. Blakemore WF, Crang AJ, Evans RJ (1983) The effect of chemical injury on oligodendrocytes. In Mimms CC, Cuzner ML, Kelly RW (Eds) Viruses and demyelinating diseases. Academic Press, London pp. 167-190.
9. Blakemore WF, Crang AJ (1988) Extensive oligodendrocyte remyelination following injection of cultured central nervous system cells into demyelinating lesions in adult central nervous system. Der Neurosci 10: 1-11.
10. 2-microglobulin in patients with AIDS dementia complex: An expanded series including response to zidovudine treatment. AIDS 6: 461-65.
11. Brück W, Schmid M, Suchamek G, Brück Y, Breitschopf H, Poser S, Piddlesen S, Lassmann H (1994) Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 35: 65-73.
12. Budka H, Costanzi G, Cristina S, Lechi A, Parravicini C, Trabattoni R, Vago L (1987) Brain pathology induced by infection with the human immunodeficiency virus (HIV) A histological, immunocytochemical and electron microscopical study of 100 autopsy cases. Acta Neuropathol 75: 185-98.
13. Budka H, Lassmann H (1988) Human immunodeficiency virus in glial cells? J Infect Dis 157: 203.
14. Budka H (1993) HIV-related dementia: Pathology and possible pathogenesis. In Scara- villi F (Ed) The neuropathology of HIV infection. Springer, Berlin pp. 171-185.
15. Cammer W, Bloom BR, Norton WT, Gordon S (1978) Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: A possible mechanism of inflammatory demyelination. Proc Natl Acad Sci (USA) 75:1554-58.
16. Ciardi A, Sinclair E, Scaravilli F, Harcourt-Webster NJ, Lucas S (1990) The involvement of the cerebral cortex in HIV encephalopathy: A morphological and immunohistochemical study. Acta Neuropathol 81:51-9.
17. Compston A, Scolding N, Wren D, Noble M (1991) The pathogenesis of demyeli- nating disease: Insights from cell biology. Trends in Neurosci 14:175-182.
18. Dal Canto MC, Rabinowitz SG (1982) Experimental models of virus-induced demyelination of the central nervous system. Ann Neurol 11: 109-27.
19. de la Monte SM, Ho DD, Schooley RT, Hirsch MS, Richardson EP Jr (1987) Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection. Neurology 37: 562-9.
20. Dubois-Dalcq ME, Zhou JM, Wilt S (1994) In vitro models to study the direct and indirect effects of HIV-1 infection of the brain. Ann Neurol 522.
21. Eilbott DJ, Peress N, Burger H (1989) Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: Expression and replication in macrophages. Proc Natl Acad Sci (USA) 86:3337-41.
22. Embretson J, Zupancic M, Beneke J, Till M, Wolinsky S, Ribas JL, Burke A, Haase AT (1993) Analysis of human immunodeficiency virus-infected tissues by application and in situ hybridisation reveals latent and permissive infections at single-cell resolution. Proc Natl Acad Sci (USA) 90:357-361.
23. Epstein LG, Sharer LR, Cho E-S, Meyenhofer MF, Navia BA, Price RW (1985) HTLV-III/LAV-like retrovirus particles in the brains of patients with AIDS encephalopathy. AIDS Res 1: 447-54.
24. Esiri MM, Morris CS, Millard PR (1991) Fate of oligodendrocytes in HIV-1 infection. AIDS 5: 1081-88.
25. Esiri MM, Kennedy PGE (1992) Virus diseases. In Adams JH, Duchen LW (Eds) Greenfield’s Neuropathology. 5th Edn, Arnold, London pp. 335-99.
26. Everall I, Luthert PJ, Lantos PL (1991) Neuronal loss in the frontal cortex in HIV infection. Lancet 2: 1119-21.
27. Franklin RJM, Crang AJ, Blakemore WF (1991) Transplanted type-1 astrocytes facilitate repair of demyelination lesions by host oligodendrocytes in adult rat spinal cord. J Neurocytol 20: 420-30.
28. Furukawa Y, Nishi K, Kondo T, Tanabe K, Mizuro Y (1992) Significance of CSF total neopterin and biopterin in inflammatory neurological diseases. J Neurol Sci 111:65-72.
29. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Risnick L, Mizrachi Y, Volsky DJ, Epstein LG, Gendelman HE (1992) Cytokines and arachidomic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: Implications for the neuropathogenesis of HIV disease. J Exp Med 176:1703-18.
30. Gilson J, Blakemore WF (1993) Failure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropathol Appl Neurobiol 19:173-181.
31. Giulian D, Vaca K, Noonan CA (1990) Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250: 1593-6.
32. Glass JD, Wesselingh SL, Selnes OA, McArthur JC (1993) Clinicopathologic correlation in HIV-associated dementia. Neurology 43: 2230-37.
33. Godfraind C, Fiedrich VL, Holmes KV, Dubois-Dalcq M (1989) In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice. J Cell Biol 109:2405-16.
34. Godfried MH, van der Poll T, Jansen J, Romijin JA, SchattenKerk J, Esiri MM, Endert E, van Deventer SJH, Sauerwein HP (1993) Soluble receptors for tumour necrosis factor: A putative marker of disease progression in HIV infection. AIDS 7: 33-36.
35. Gray F, Chimelli C, Mohr M, Clavelou P, Scaravilli F, Poirier J (1991) Fulminating multiple sclerosis-like leukoencephalopathy revealing human immunodeficiency virus infection. Neurology 41:105-109.
36. Gray F, Belec L, Keohane C, de Trachis P, Clair B, Durigon M, Sobel A, Gherardi R (1994) Zidovudine therapy and HIV encephalitis: A 10-year neuropathological survey. AIDS 8: 489-93.
37. Griffin DE, Wesselingh SL, McArthur JC (1994) Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann Neurol 35: 592-7.
38. Gyorkey F, Melnick JL, Gyorkey P (1987) Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy. J Infect Dis 155: 870-76.
39. Harouse JM, Bhat S, Spitalnik SL, Laughlin M, Stefano K, Silberberg DH, Gon- zalez-Scarano F (1991) Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253: 320-23.
40. Hofmann B, Nishamian P, Fahey JZ, Esmail I, Jackson AL, Detels R, Cumberland W (1991) Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: Distinctive parameters of HIV-induced change. Clin Immunol Immunopathol 61: 212-24.
41. Holmes AH, Esiri M, Morris CS, Edwards A (1992) Central pontine myelinolysis in a patient with AIDS. J Neurol Neurosurg Psychiat 55: 631-2.
42. Honda M, Kitamura K, Matsuda K, Yokota Y, Yamamoto N, Mitsuyasu R, Cher- mann JC, Tokunaga T (1989) Soluble IL-2 receptor in AIDS. Correlation of its serum level with the classification of HIV-induced diseases and its characterisation. J Immunol 142: 4248-55.
43. Huber CL, Batchelor JR, Fuchs D, Hansen A, Lang A, Niederweiser D, Reibneg- ger G, Swetly P, Troppmair J, Wachter H (1984) Immune response-associated production of neopterin: Release from macrophages primarily under control of interferon-gamma. J Exp Med 160: 310-16.
44. Johnson ES, Ludwin SK (1981) The demonstration of recurrent demyelination and remyelination of axons in the central nervous system. Acta Neuropathol 53:93-8.
45. Ketzler S, Weis S, Haug H, Budka H (1990) Loss of neurons in the frontal cortex of AIDS brains. Acta Neuropathol 80:92-4.
46. Kimura-Kuroda J, Nagashima K, Yasui K (1992) Binding of HIV-1 gp 120 to oligodendrocytes and its effects on myelination in primary cultures of rat cerebral cortex. In Neuroscience of HIV infection-Basic and Clinical Frontiers. Amsterdam, The Netherlands.
47. Langley OK, Ghandour MS, Vincendon G, Gombos G (1980) Carbonic anhydrase: An ultrastructural study in rat cerebellum. Histochem J 12:473-83.
48. Liebowitz S, Hughes RAC (1983) Immunology of the nervous system. Arnold, London.
49. Lieberman AP, Pitha PM, Shin HS, Shin ML (1989) Production of tumour necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci (USA) 86:6348-52.
50. Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y, Lu HC, Lassmann H, Werkerle H (1993) T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 23: 1364-72.
51. Lipton SA (1992) Models of neuronal injury in AIDS: Another role for the NMDA receptor? Trends in Neurosci 15:75-79.
52. Louis JC, Magal E, Takayama S, Varon S (1993) CNTF protection of oligodendrocytes against natural and tumour necrosis factor-induced death. Science 259: 689-92.
53. Ludwin SK (1980) Chronic demyelination inhibits remyelination in the central nervous system. Lab Invest 43:382-7.
54. Maier H, Budka H, Lassmann H, Pohl P (1989) Vacuolar myelopathy with multi- nucleated giant cells in the acquired immune-deficiency syndrome (AIDS). Light and electron microscopic distribution of human immunodeficiency virus (HIV) antigens. Acta Neuropathol 78: 497-503.
55. McArthur JC, Beck PS, Parisi JE, Trapp B, Selnes OA, Cornblath DR, Balakrish- nan J, Griffin JW, Price D (1989) Neuropathological changes in early HIV-1 dementia. Ann Neurol 26: 681-4.
56. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NMH, McArthur JH, Selnes OA, Jacobson LP, Visscher BR, Concha M, Saah A (1993) Dementia in AIDS patients: Incidence and risk factors. Neurology 43: 2245-2252.
57. Merrill JE, Zimmerman RP (1991) Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGF^. Glia 4:327-31.
58. Mitrovic B, Ignarro LJ, Montestruque S, Smoll A, Merrill JE (1994) Nitric oxide as a potential pathological mechanism in demyelination: Its differential effects on primary glial cells in vitro. Neuroscience 61: 575-85.
59. Morris CS, Esiri MM, Sprinkle TJ, Gregson N (1994) Oligodendrocyte reactions and cell proliferation markers in human demyelinating diseases. Neuropathol Appl Neurobiol 20: 272-81.
60. Navia BA, Cho E-S, Petito CK, Price RW (1986) The AIDS dementia complex II. Neuropathology. Ann Neurol 19: 525-35.
61. Petito CK, Navia BA, Cho E-S, Jordan BDE, George DC, Price RW (1985) Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with acquired immunodeficiency syndrome. New Engl J Med 312: 874-9.
62. Petito CK, Cash KS (1992) Blood-brain abnormalities in the acquired immunodeficiency syndrome: Immunohistochemical localisation of serum proteins in post mortem brain. Ann Neurol 32: 658-66.
63. Petito CK, Vecchio D, Chen Y-T (1994) HIV antigen and DNA in AIDS joined cords correlate with a macrophage infiltration but not with vacuolar myelopathy. J Neuropathol Exp Neurol 53: 86-94.
64. Poli G, Bressler P, Kinter A, Duh E, Tinmer WC, Rabson A, Justement JS, Stanley S, Fauci AS (1990) Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the mono cyte/macrophage lineage. J Exp Med 173:589-97.
65. Power C, Kong P-A, Crawford TO, Wesselingh S, Glass JD, McArthur JC, Trapp BD (1993) Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain-barrier. Ann Neurol 34:339-50.
66. Prayoonwiwat N, Rodriguez M (1993) The potential for oligodendrocyte proliferation during demyelinating disease. J Neuropathol Exp Neurol 52:55-63.
67. Price RW, Brew BJ (1988a) The AIDS dementia complex. J Infect Dis 158:1079-83.
68. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P (1988b) The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586-92.
69. Prince HE, Kleinman S, Williams AE (1988) Soluble IL-2 receptor levels in serum from blood donors seropositive for HIV. J Immunol 140:1139-41.
70. Prineas JW, Kwon EE, Goldenberg PZ, Ilyas AA, Quarles RH, Benjamin JA, Sprinkle TJ (1989) Multiple sclerosis: Oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 61:489-503.
71. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho E-S (1993) Multiple sclerosis: Remyelination of nascent lesions. Ann Neurol 33:137-151.
72. Raff MC (1989) Glial cell diversification in the rat optic nerve. Science 243:1450-55.
73. Raff MC, Barres BA, Burne JF, Coles HS, Jacobson MD (1993) Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 262:695-699.
74. Reddy MM, Grieco MH (1988) Elevated soluble interleukin-2 receptor levels in serum of human immunodeficiency virus infected populations. AIDS Res Hum Retroviruses 4:115-20.
75. Reddy MM, McKinley G, Englard A, Grieco MH (1990) Effect of azidothymi- dine (AZT) on HIV p24 antigen, beta 2-microglobulin, neopterin, soluble CD8, soluble interleukin-2 receptor and tumour necrosis factor alpha levels in patients with AIDS-related complex or AIDS. Int J Immunopharmacol 12:737-41.
76. Reynolds R, Wilkin GP (1993) Cellular reaction to an acute demyelinating/remyelinating lesion in the rat brainstem-localisation of GD3 ganglioside immunoreactivity. J. Neurosci Res 36:417-34.
77. Rhodes RH, Ward JM, Cowan RP, Moore PT (1989) Immunohisto-chemical localisation of human immunodeficiency viral antigens in formalin-fixed cords with AIDS myelopathy. Clin Neuropathol 8:22-7.
78. Rieckmann P, Poli G, Kehrl JH, Fauci AS (1991) Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a pro-monocyte cell line. J Exp Med 173:1-5.
79. Robertson KR, Stern RA, Hall CD, Perkins DO, Wilkins JW, Gortner DT, Donovan K, Messenheimer JA, Whaley R, Evans DL (1993) Vitamin B12 deficiency and nervous system disease in HIV infection. Arch Neurol 50:807-11.
80. Rodriguez M, Oleszak E, Leibowitz J (1987) Theiler’s murine encephalomyelitis: A model of demyelination and persistence of virus. CRC Crit Rev Immunol 7:325-65.
81. Rodriguez M, Lindsley M (1992) Immunosuppression promotes central nervous system remyelination in chronic virus-induced demyelinating disease. Neurology 42: 348-57.
82. Saneto RP, Altman A, Knobler RL, Johnson HW, De Vellis J (1986) Interleukin-2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro. Proc Natl Acad Sci (USA) 83: 9221-5.
83. Schmidbauer M, Budka H, Okeda R, Cristina S, Lechi A, Trabattoni GR (1990) Multifocal vacuolar leukoencephalopathy: A distinct HIV-associated lesion of the brain. Neuropathol Appl Neurobiol 16:437-43.
84. Schoedon G, Troppmair J, Adolf G, Huber C, Niederweiser A (1986) Interferon P enhances biosynthesis of pterins in peripheral blood mononuclear cells by induction of GTP-cyclo-hydrolase 1 activity. J Interferon Res 6:697-703.
85. Schoedon G, Troppmair J, Fontana A, Huber C, Curtius H-C, Niederweiser A (1987) Biosynthesis and metabolism of pterins in peripheral blood mononuclear cells and leukaemia lines of man and mouse. Eur J Biochem 166:303-10.
86. Schulte C, Meurer M (1989) Soluble IL-2 receptor serum levels-a marker for disease progression in patients with HIV-1 infection. Arch Dermatol Res 281:299-303.
87. Scolding NJ, Houston WA, Morgan BP, Campbell AK, Compston DA (1989) Reversible injury of cultured rate oligodendrocytes by complement. Immunology 67:441-6.
88. Scolding NJ, Morgan BP, Frith SJ (1990a) Intracellular calcium and oligodendrocyte injury. J Neurol Neurosurg Psychiat 53: 811 (Abs).
89. Scolding NJ, Jones J, Compston DAS, Morgan BP (1990b) Oligodendrocyte susceptibility to injury by T-cell perforin. Immunology 70:6-10.
90. Scolding NJ, Compston DAS (1991) Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodies. Immunology 72:127-32.
91. Scott-Algara D, Vuillier F, Marasescu M, de Saint-Martin J, Dighiero G (1991) Serum levels of IL-2, IL-1 alpha, TNF-alpha and soluble receptor of IL-2 in HIV-infected patients. AIDS Res Hum Retroviruses 7:381-6.
92. Selmaj KW, Raine CS (1988) Tumour necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339-46.
93. Selmaj K, Raine CS, Farooq M (1991) Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol 147:1522-9.
94. Sharer LR, Prineas JW (1988) Human immunodeficiency virus in glial cells. J Infect Dis 157:204.
95. Sharer LR, Dowling PC, Michaels J, Cook SD, Menonna J, Blumberg BM, Epstein LG (1990) Spinal cord disease in children with HIV-1 infection: A combined molecular biological and neuropathological study. Neuropathol Appl Neurobiol 16:317-31.
96. Sharer LR, Mintz M (1993) Neuropathology of AIDS in children. In Scaravilli F (Ed) The neuropathology of HIV infection. Springer, Berlin pp. 201-214.
97. Smith I, Howells DW, Kendall B, Levinsky R, Hyland K (1987) Folate deficiency and demyelination in AIDS. Lancet 2:215.
98. Smith TW, De Girolami U, Henin D, Bolgert F, Hauw J-J (1990) Human immunodeficiency virus (HIV) leucoencephalopathy and the microcirculation. J Neu- ropathol Exp Neurol 49:357-70.
99. Sprinkle TJ (1989) 2’, 3’-cyclic nucleotide 3’-phosphodiesterase, an oligodendro- cyte-Schwann cell and myelin-associated enzyme of the nervous system. CRC Crit Revs Neurobiol 4: 235-301.
100. Stanley LC, Mrak RE, Woody RC, Perrot LJ, Zhang SX, Marshak DR, Nelson SJ, Griffin WST (1994) Glial cytokines as neuropathogenic factors in HIV infection: Pathogenic similarities to Alzheimer’s disease. J Neuropathol Exp Neurol 53:231-38.
101. Stoler MH, Eskin TA, Benn S, Angerer RC, Angerer LM (1986) Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis. JAMA 256:2381-83.
102. Surtees R, Leonard J, Austin S (1991) Association of demyelination with deficiency of cerebrospinal fluid S-adenosylmethionine in inborn errors of methyl- transfer pathway. Lancet 338:1550-54.
103. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L (1994) Central nervous system damage produced by expression of the HW-1 coat protein gp120 in transgenic mice. Nature 367:188-193.
104. Tsunetsugu-Yokota Y, Honda M (1990) Effect of cytokines on HIV release and IL-2 receptor alpha expression in monocytic cell lines. J AIDS 3:511-16.
105. Tyor WR, Glass JD, Baumrind N, McArthur JC, Griffin JW, Becker PS, Griffin DE (1993) Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology 43:1002-9.
106. von Briesen H, von Mallinkrodt C, Esser R, Muller S, Becker K, Rubsamen- Waigmann H, Andreesen R (1991) Effect of cytokines and lipopolysaccharides on HIV infection of human macrophages. Res Virol 142:197-204.
107. Watanabe R, Wege H, Termeulen V (1983) Adoptive transfer of EAE-like lesions from rats with corona virus-induced demyelinating encephalomyelitis. Nature 305:150-3.
108. Weiser B, Peress N, La Neve D, Eilbott DJ, Seidman R, Burger H (1990) Human immunodeficiency virus type 1 expression in the central nervous system correlates directly with the extent of the disease. Proc Natl Acad Sci (USA) 87:3997-4001.
109. Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, Farber JM, Griffin JW, Griffin DE (1993) Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 33:576-82.
110. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA (1986) Cellular localisation of human immunodeficiency virus infection within the brains of acquired immunodeficiency syndrome patients. Proc Natl Acad Sci (USA) 83:7089-7093.
111. Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R (1991) Neocortical damage during HIV infection. Ann neurol 29:651-57.
112. Wren DR, Noble M (1989) Oligodendrocytes and oligodendrocyte/-type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody. Proc Natl Acad Sci (USA) 86: 9025-29.
113. Zajicek JP, Wing M, Scolding NJ, Compston DAS (1992) Interactions between oligodendrocytes and microglia. Brain 115:1611-31.